Brief: Amarin And Csl Seqirus Announce Exclusive License And Distribution Agreement To Commercialize Vazkepa In Australia And New Zealand

Amarin

28/02/2023 13:05

Feb 28 (Reuters) - Amarin Corporation PLC  AMRN.O :
    * AMARIN AND CSL SEQIRUS ANNOUNCE EXCLUSIVE LICENSE AND
DISTRIBUTION AGREEMENT TO COMMERCIALIZE VAZKEPA (ICOSAPENT
ETHYL) IN AUSTRALIA AND NEW ZEALAND
    * UNDER TERMS OF AGREEMENT, CSL SEQIRUS WILL IN-LICENSE
VAZKEPA
FROM AMARIN
    * CSL SEQIRUS TO BE RESPONSIBLE FOR MARKET ACCESS,
REIMBURSEMENT
EFFORTS, DISTRIBUTION, FOR VAZKEPA ACROSS AUSTRALIA, NEW ZEALAND
    * AMARIN WILL RECEIVE AN UPFRONT PAYMENT AND BE ELIGIBLE FOR
EVENT-RELATED MILESTONE PAYMENTS OF UP TO APPROXIMATELY $8
MILLION
    * AMARIN WILL RECEIVE ADDITIONAL PRODUCT-RELATED MILESTONE
PAYMENTS OF UP TO APPROXIMATELY $4 MILLION

Source text for Eikon:  ID:nGNX3cGcwP 
Further company coverage:  AMRN.O